|
|
medical advisors |
|
Dr. Matthew Akiyama
Dr. Akiyama is an assistant professor of medicine and clinician-investigator at Albert Einstein college of medicine and Montefiore medical center. In addition to providing care and treatment to people living with HIV, hepatitis c virus (HCV), and substance use disorders, dr. Akiyama conducts research focusing on HCV among socioeconomically marginalized populations with particular emphasis on the intersection of HCV in the criminal justice system and sub-Saharan Africa. Dr. Akiyama is the recipient of a k99/r00 award from the national institute on drug abuse to develop and test an innovative strategy to improve linkage to and retention in HCV treatment among individuals recently released from jail. He is also the recipient of an Avenir award from Nida focused on HCV transmission networks among people who inject drugs in Kenya.
Dr. Akiyama is an assistant professor of medicine and clinician-investigator at Albert Einstein college of medicine and Montefiore medical center. In addition to providing care and treatment to people living with HIV, hepatitis c virus (HCV), and substance use disorders, dr. Akiyama conducts research focusing on HCV among socioeconomically marginalized populations with particular emphasis on the intersection of HCV in the criminal justice system and sub-Saharan Africa. Dr. Akiyama is the recipient of a k99/r00 award from the national institute on drug abuse to develop and test an innovative strategy to improve linkage to and retention in HCV treatment among individuals recently released from jail. He is also the recipient of an Avenir award from Nida focused on HCV transmission networks among people who inject drugs in Kenya.
Dr. Brianna Norton
Dr. Brianna Norton is an assistant professor of medicine in the divisions of general internal medicine and infectious diseases at albert Einstein college of medicine/Montefiore medical center. Her clinical work includes the treatment of HIV, hepatitis c and opioid dependence in the primary care setting. She conducts research to improve linkage to HCV care and treatment for people who inject drugs. She is also the medical director of the NY harm reduction educators, a syringe exchange program in East Harlem and the south Bronx.
Dr. Brianna Norton is an assistant professor of medicine in the divisions of general internal medicine and infectious diseases at albert Einstein college of medicine/Montefiore medical center. Her clinical work includes the treatment of HIV, hepatitis c and opioid dependence in the primary care setting. She conducts research to improve linkage to HCV care and treatment for people who inject drugs. She is also the medical director of the NY harm reduction educators, a syringe exchange program in East Harlem and the south Bronx.
Dr. Tatyana Kushner
Dr. Tatyana Kushner is a leader in the management of hepatitis c, hepatitis b, and other liver diseases during pregnancy. Dr. Kushner works with patients in the division of liver diseases and in obstetrics, gynecology, and reproductive science. Her clinical practice encompasses the full spectrum of liver diseases, with a focus on viral hepatitis (hepatitis b, c, and d) and individuals with liver disease, including pregnancy-related liver conditions and reproductive health as it pertains to liver disease.
Dr. Tatyana Kushner is a leader in the management of hepatitis c, hepatitis b, and other liver diseases during pregnancy. Dr. Kushner works with patients in the division of liver diseases and in obstetrics, gynecology, and reproductive science. Her clinical practice encompasses the full spectrum of liver diseases, with a focus on viral hepatitis (hepatitis b, c, and d) and individuals with liver disease, including pregnancy-related liver conditions and reproductive health as it pertains to liver disease.
Dr. Jaime Chu
Dr. Jaime Chu is the Medical Director of Pediatric Liver Transplantation at the Recanati/Miller Transplantation Institute at Mount Sinai. Her team has been involved in the early and ongoing studies of HBV and HCV treatments in children, and continue to treat many children with viral hepatitis. In addition, Dr. Chu is an NIH-funded clinician-scientist whose research is focused on better understanding and identifying treatments for liver fibrosis.
Nadia Ovchinsky
Nadia Ovchinsky, MD, MBA is the Director of Pediatric Hepatology, Medical Director of Pediatric Liver Transplantation, and a Professor of Pediatrics at Albert Einstein College of Medicine - Children's Hospital at Montefiore. Dr. Ovchinsky received her MD and MBA in Healthcare Management from Rutgers-Robert Wood Johnson Medical School. She completed her pediatric residency, pediatric gastroenterology fellowship, as
well as advanced training in pediatric transplant hepatology at Columbia University - Morgan Stanley Children's Hospital of New York-Presbyterian. Dr. Ovchinsky’s research interests involve improving quality and enhancing the delivery care for children with chronic liver disease, optimizing outcomes of pediatric liver transplantation, and
advancing therapies for children with cholestatic liver disorders and viral hepatitis. In addition to Dr. Ovchinsky’s role as a clinician, teacher, and researcher, she is actively involved in public policy and advocacy efforts to benefit children with liver disease. She
has served in leadership positions with professional societies such as the American Association for the Study of Liver Diseases, the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition and the American Liver Foundation. Dr. Ovchinsky has been recognized with numerous academic and humanism in medicine awards, as well as teaching awards for her commitment and dedication to the education of medical students, residents, and fellows.
Nadia Ovchinsky, MD, MBA is the Director of Pediatric Hepatology, Medical Director of Pediatric Liver Transplantation, and a Professor of Pediatrics at Albert Einstein College of Medicine - Children's Hospital at Montefiore. Dr. Ovchinsky received her MD and MBA in Healthcare Management from Rutgers-Robert Wood Johnson Medical School. She completed her pediatric residency, pediatric gastroenterology fellowship, as
well as advanced training in pediatric transplant hepatology at Columbia University - Morgan Stanley Children's Hospital of New York-Presbyterian. Dr. Ovchinsky’s research interests involve improving quality and enhancing the delivery care for children with chronic liver disease, optimizing outcomes of pediatric liver transplantation, and
advancing therapies for children with cholestatic liver disorders and viral hepatitis. In addition to Dr. Ovchinsky’s role as a clinician, teacher, and researcher, she is actively involved in public policy and advocacy efforts to benefit children with liver disease. She
has served in leadership positions with professional societies such as the American Association for the Study of Liver Diseases, the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition and the American Liver Foundation. Dr. Ovchinsky has been recognized with numerous academic and humanism in medicine awards, as well as teaching awards for her commitment and dedication to the education of medical students, residents, and fellows.
Dr. Leah Habersham
Dr. Leah Habersham is an Addiction Medicine Specialist as well as an Obstetrician & Gynecologist (OBGYN).
As an OBGYN-Addiction Specialist and Clinical Researcher, Dr. Habersham’s primary mission is to serve as a bridge between the two specialties—providing evidence-based whole-person healthcare for marginalized women. Dr. Habersham leads an integrated OBGYN-Addiction treatment program within the Mount Sinai Health System, and also provides opioid treatment at the sole female-only outpatient treatment program in NY state.
Dr. Leah Habersham is an Addiction Medicine Specialist as well as an Obstetrician & Gynecologist (OBGYN).
As an OBGYN-Addiction Specialist and Clinical Researcher, Dr. Habersham’s primary mission is to serve as a bridge between the two specialties—providing evidence-based whole-person healthcare for marginalized women. Dr. Habersham leads an integrated OBGYN-Addiction treatment program within the Mount Sinai Health System, and also provides opioid treatment at the sole female-only outpatient treatment program in NY state.